CoChat

A Review of Interleukin‐2 Receptor Antagonists in Solid Organ Transplantation

Berard, Jennifer L., Velez, Rebecca L., Freeman, Richard B., Tsunoda, Shirley M. · 1999 · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Cited by 67

The DOI matches its Crossref record.

Abstract

Daclizumab and basiliximab, engineered human IgG monoclonal antibodies to the interleukin‐2 (IL‐2) receptor α‐subunit, were approved to prevent acute rejection after rnal transplantation. Daclizumab was studied in adult and pediatric renal allograft recipients, liver allograft recipients, and calcineurin‐sparing protocols in renal transplant recipients. Basiliximab was studied in renal allograft recipients and subgroups of recipients of living‐related and cadaveric transplants, and in patients with diabetes mellitus. Both agents reduced acute rejection and were associated with few adverse effects. However, information regarding their long‐term effects on infection, malignancy, chronic rejection, and patient survival must be available before a final decision is made regarding their proper administration. We propose that a likely role the drugs will play in the field of solid organ transplantation is in new protocols that allow sparing of other more toxic immunosuppressive agents.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1592/phco.19.15.1127.30582

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 67

Metadata

Authors
Berard, J. L., Velez, R. L., Freeman, R. B., & Tsunoda, S. M.
Venue
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Publisher
Wiley
Published
1999-10
Volume
19
Issue
10
Pages
1127-1137
ISSN
  • 0277-0008 (ISSN-L)
  • 1875-9114
OpenAlex
W2154036132
Cited by
67
References
0
FWCI
5.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Review of Interleukin‐2 Receptor Antagonists in Solid Organ Transplantation. https://app.cochat.ai/papers/10.1592/phco.19.15.1127.30582
The paper
Berard, J. L., Velez, R. L., Freeman, R. B., & Tsunoda, S. M. (1999). A Review of Interleukin‐2 Receptor Antagonists in Solid Organ Transplantation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.19.15.1127.30582

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.